Science Explorer Back to mapMap
Discussion
Researcher · Centre Léon Bérard · France

Pierre Saintigny

Pierre Saintigny publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics and Head and Neck Cancer Studies.

ORCID 0000-0002-8090-9323 OpenAlex
World rank
#343,643
of 7,710,434 ranked researchers
Rank in France
#19,305
of 324,115
Works
617
Citations
8.7k
Citations per work
14.0
h-index
44
i10-index 103Top 5.1% in Oncology
Pierre Saintigny

What does Pierre Saintigny research?

Pierre Saintigny's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (24%).

Health Sciences: 304 works · 49.3% of their workMedicine: 304 works · 49.3% of their workOncology: 125 works · 20.2% of their workPulmonary and Respiratory Medicine: 114 works · 18.4% of their workOtorhinolaryngology: 41 works · 6.7% of their workRadiology, Nuclear Medicine and Imaging: 25 works · 4.0% of their workEverything else: 164 works · 26.5% of their workLife Sciences: 149 works · 24.2% of their workBiochemistry, Genetics and Molecular Biology: 149 works · 24.2% of their workMolecular Biology: 83 works · 13.5% of their workCancer Research: 66 works · 10.7% of their workTHEIR WORKPierre Saintigny617works
Life Sciences24%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine30449.3%
  2. Everything else16426.5%
    1. Biochemistry, Genetics and Molecular Biology14924.2%
  1. 1Oncology20% of their works
  2. 2Pulmonary and Respiratory Medicine18% of their works
  3. 3Molecular Biology14% of their works
  4. 4Cancer Research11% of their works
  5. 5Otorhinolaryngology7% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Pierre Saintigny's research?

The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Tumor Microenvironment, Cancer Genomics and Mutational Signatures.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Targeted Therapy1393 topics
  2. Clinical Trials872 topics
  3. Chemotherapy732 topics
  4. ALK Inhibitors641 topic
  5. EGFR Mutations641 topic
  6. Tumor Microenvironment622 topics
  7. Cancer Genomics521 topic
  8. Mutational Signatures521 topic
  9. Human Papillomavirus501 topic
  10. Oropharyngeal Cancer501 topic
  11. Immune Checkpoint Blockade371 topic
  12. PD-1 and PD-L1371 topic
  13. Cancer251 topic
  14. Ferroptosis251 topic
  15. Genomic Profiles231 topic
  16. Small-Cell Lung Cancer231 topic
  17. Oral Mucosal Disorders221 topic
  18. Potentially Malignant Disorders221 topic
  19. RNA methylation191 topic
  20. m6A-seq191 topic

Where does Pierre Saintigny work?

Pierre Saintigny's main affiliation in the publication record is Centre Léon Bérard, France.

How many publications and citations does Pierre Saintigny have?

OpenAlex counts 617 works and 8,666 citations for Pierre Saintigny, an h-index of 44, ranking #343,643 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Pierre Saintigny

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Pierre Saintigny. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.